Phase I trial: the use of autologous cultured adipose-derived stroma/stem cells to treat patients with non-revascularizable critical limb ischemia.

[1]  F. Moll,et al.  Autologous Bone Marrow–Derived Cell Therapy in Patients With Critical Limb Ischemia: A Meta-Analysis of Randomized Controlled Clinical Trials , 2013, Annals of surgery.

[2]  C. Jorgensen,et al.  Long-term detection of human adipose-derived mesenchymal stem cells after intraarticular injection in SCID mice. , 2013, Arthritis and rheumatism.

[3]  Louis Casteilla,et al.  Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). , 2013, Cytotherapy.

[4]  Lei Chen,et al.  OCT4 Positively Regulates Survivin Expression to Promote Cancer Cell Proliferation and Leads to Poor Prognosis in Esophageal Squamous Cell Carcinoma , 2012, PloS one.

[5]  R. Powell.  Update on clinical trials evaluating the effect of biologic therapy in patients with critical limb ischemia. , 2012, Journal of vascular surgery.

[6]  H. Guadalajara,et al.  Autologous Expanded Adipose-Derived Stem Cells for the Treatment of Complex Cryptoglandular Perianal Fistulas: A Phase III Randomized Clinical Trial (FATT 1 Fistula Advanced Therapy Trial 1) and Long-term Evaluation , 2012, Diseases of the colon and rectum.

[7]  T. Hong,et al.  Safety and effect of adipose tissue-derived stem cell implantation in patients with critical limb ischemia: a pilot study. , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[8]  C. Jorgensen,et al.  Long-term detection of human adipose tissue-derived mesenchymal stem cells after intra-articular injection , 2012 .

[9]  G. Kitsios,et al.  Improved amputation-free survival in unreconstructable critical limb ischemia and its implications for clinical trial design and quality measurement. , 2012, Journal of vascular surgery.

[10]  K. Tarte,et al.  Limited acquisition of chromosomal aberrations in human adult mesenchymal stromal cells. , 2012, Cell stem cell.

[11]  K. Hayashi,et al.  Gene and protein expression analysis of mesenchymal stem cells derived from rat adipose tissue and bone marrow. , 2011, Circulation journal : official journal of the Japanese Circulation Society.

[12]  T. Iwama,et al.  Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy. , 2011, Cytotherapy.

[13]  Bing Chen,et al.  Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial. , 2011, Diabetes research and clinical practice.

[14]  L. Casteilla,et al.  Native human adipose stromal cells: localization, morphology and phenotype , 2011, International Journal of Obesity.

[15]  B. Cousin,et al.  Vascular and endothelial regeneration. , 2010, Current stem cell research & therapy.

[16]  F. Acín,et al.  Meta-analysis of randomized, controlled clinical trials in angiogenesis: gene and cell therapy in peripheral arterial disease , 2009, Heart and Vessels.

[17]  T. Murohara,et al.  Implantation of Adipose-Derived Regenerative Cells Enhances Ischemia-Induced Angiogenesis , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[18]  H. Matsubara,et al.  Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia. , 2008, American heart journal.

[19]  G. Glinsky.  "Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  Kenneth Cornetta,et al.  Suppression of Hepatocyte Growth Factor Production Impairs the Ability of Adipose‐Derived Stem Cells to Promote Ischemic Tissue Revascularization , 2007, Stem cells.

[21]  Yao‐Hua Song,et al.  The cardioprotective effect of mesenchymal stem cells is mediated by IGF-I and VEGF. , 2007, Biochemical and biophysical research communications.

[22]  Hyunjin Cho,et al.  Direct Comparison of Human Mesenchymal Stem Cells Derived from Adipose Tissues and Bone Marrow in Mediating Neovascularization in Response to Vascular Ischemia , 2007, Cellular Physiology and Biochemistry.

[23]  L. Norgren,et al.  Inter-society consensus for the management of peripheral arterial disease. , 2007, International angiology : a journal of the International Union of Angiology.

[24]  J. Gimble,et al.  Adipose-derived stem cells for regenerative medicine. , 2007, Circulation research.

[25]  Y. Bae,et al.  Human Adipose Tissue-Derived Mesenchymal Stem Cells Improve Postnatal Neovascularization in a Mouse Model of Hindlimb Ischemia , 2006, Cellular Physiology and Biochemistry.

[26]  Tomoyuki Nishikawa,et al.  Novel Autologous Cell Therapy in Ischemic Limb Disease Through Growth Factor Secretion by Cultured Adipose Tissue–Derived Stromal Cells , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[27]  Q. Han,et al.  Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. , 2005, Biochemical and biophysical research communications.

[28]  Stefanie Dimmeler,et al.  Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies. , 2004, Circulation.

[29]  Keith L. March,et al.  Secretion of Angiogenic and Antiapoptotic Factors by Human Adipose Stromal Cells , 2004, Circulation.

[30]  B. Lévy,et al.  Plasticity of Human Adipose Lineage Cells Toward Endothelial Cells: Physiological and Therapeutic Perspectives , 2004, Circulation.

[31]  K. Shimada,et al.  Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial , 2002, The Lancet.

[32]  E. Hiyama,et al.  Clinical utility of telomerase in cancer , 2002, Oncogene.

[33]  W. James,et al.  Buerger's Disease , 1989, International journal of dermatology.

[34]  Xuehao Wang,et al.  OCT4 regulates epithelial-mesenchymal transition and its knockdown inhibits colorectal cancer cell migration and invasion. , 2013, Oncology reports.

[35]  L. Norgren,et al.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). , 2007, Journal of vascular surgery.

[36]  R. Rutherford,et al.  Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). , 2000, Journal of vascular surgery.